Gut Microbiota-Based Clinical Study of Akkermansia Supplementation for Overweight and Obesity | MicrobiomeTrials← Back to trialsNCT07898267
Gut Microbiota-Based Clinical Study of Akkermansia Supplementation for Overweight and Obesity
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2027-01-01Est. Completion: 2028-09-01
Enrollment target: 150 participants Locations- No. 1, Minde Road, Donghu District, Nanchang University Second Affiliated Hospital, Nanchang, Jiangxi, China
Other microbiome trials you might be interested in
Diabetes MellitusObesityFatty Liver
Background:
Children s weight has increased sharply in recent years. This may put them at higher risk for health proble…
Phoenix, United StatesEst. completion Dec 31, 2041
Obesity
Sarcopenia, a condition where individuals lose muscle mass and strength, is associated with poorer health and function. …
Singapore, SingaporeCompleted May 31, 2026
Diabetes Type 2Overweight or Obesity
The goals of this randomized trial is to learn:
1. If the Thrive AI Health app will help adults improve their everyday …
New Haven, United StatesEst. completion Jan 2027